ALL RAW MATERIALS ARE NOT CREATED EQUAL.
|
|
- Godfrey Wiggins
- 6 years ago
- Views:
Transcription
1 ALL RAW MATERIALS ARE NOT CREATED EQUAL. Meet Diagnostics Elite DIAGNOSTIC SOLUTIONS Reimagine what s possible.
2 REDUCE RISK. INCREASE CONSISTENCY. The Diagnostics Elite program is more than just a set of raw materials. It is an investment in your future product security. Diagnostics Elite Program Attributes: Increased control over manufacturing processes to ensure consistent product performance Enhanced change control notification Supply chain control and transparency Extensive documentation to meet current requirements Elevated quality and supply chain support We understand that developing and manufacturing IVD assays is a complex process involving critical raw materials that can affect assay performance. We also recognize that IVD industry regulations are complex and evolving. In such an environment, small inconsistencies in raw materials can lead to significant disruptions in assay design, delays in manufacturing, and affect assay performance. It is why we have developed Diagnostics Elite, an enhanced portfolio of raw materials that promotes consistency across your entire assay manufacturing process. Every Diagnostics Elite raw material is designed with a focus on improving manufacturing efficacy while minimizing your level of risk. TYPES OF RISK IN IVD MANUFACTURING COST RISK MANAGEMENT $$$$$ Product recall $$$$ $$$ Backorder Patient misdiagnosis or patient harm $$ Delay in manufacturing Batch failure $ SEVERITY Sigma-Aldrich Corporation The Diagnostics Elite Program 2
3 THE DIAGNOSTICS ELITE ADVANTAGE. With the Diagnostics Elite program, we have leveraged our knowledge of the IVD industry, regulations and customer requirements and merged these with our expertise in quality and supply chain enhancements to provide you the level of transparency needed throughout the product s lifecycle. As part of the Sigma-Aldrich Enhanced Quality Program, Diagnostics Elite products are categorized by intended use, requirements for documentation, supply chain transparency and other quality attributes. With a better understanding of these raw material attributes, you can effectively align your raw material plans with our offering. STANDARD PRODUCTS VS DIAGNOSTICS ELITE PRODUCTS Key Attributes of the Diagnostics Elite Products Quality by design - Failure modes and effects analysis (FMEA) and critical control parameters - QA batch reviews Increased consistency - 12 week change control notification - Vendor management for raw materials and finished goods Enhanced service - Retained batch samples - Higher priority for quality complaints and investigations Optimized products - Additional specifications for intended applications - Stability data for GMP products SIGMA-ALDRICH ENHANCED QUALITY GUIDELINES Diagnostics Elite Products Attributes Product Use Raw Material Regulatory Requirements Standard Research, Industrial and Chemical Specialities Non-Regulated Applications Premium Research, Industrial and Chemical Specialities Non-Regulated Applications Quality Systems Controls ISO 9001 ISO 9001 Sourcing Information Analytical Methods Certificate of Analysis Change Control Notification Product Specification Certificate of Origin Expiry or Retest Date Vendor Assessment Critical Control Parameter (CCP) QA Batch Review Lot Sample Retained Vendor Management Validation Proprietary Discretionary Confidential Information Shared Under CDA Elite IVD Manufacturing and Biopharma Processing Regulated Applications ISO 9001 plus other Controlled Processes Confidential Information Shared Under CDA GMP/Compendia API, BPE, IVD, Biopharma Applications Regulated Applications ICH Q7, IPEC, 21 CFR, Confidential Information Shared Under CDA For more information, visit sigma-aldrich.com/diagnostics 3
4 CONSISTENCY AND TRANSPARENCY Change Control Notification Program Our commitment to maintaining consistent manufacturing processes for Diagnostics Elite and GMP products. We understand that changes in critical raw material may require an IVD manufacturer to perform extensive impact analysis and validation. To reduce this risk and communicate changes in a timeframe that would limit the impact to commercialization, we have implemented advanced change control for Diagnostics Elite and GMP products. When changes are unavoidable, we are committed to providing you with advanced notification as quickly as possible. See Notifiable Events below for more details. EXAMPLE NOTIFIABLE EVENTS AND TIMEFRAMES Notifiable Events Standard Premium Elite GMP Expiry or Recommended Retest Date Immediate Immediate Immediate Immediate Storage Temperature Immediate Immediate Immediate Immediate EQP Status Downgrade N/A Immediate Immediate Immediate Product Recalls and Alerts Immediate Immediate Immediate Immediate Product Master Data (Examples- Name, Formula weight, CAS#, etc.) Immediate Immediate Immediate Immediate Label Changes (Examples- CAS, Formula, Storage Temp, Weights) Immediate Immediate Immediate Immediate Procured Product: Country of Origin (if known) 2 weeks 4 weeks 12 weeks 12 weeks Vendor (company we place our PO with) 2 weeks 4 weeks 12 weeks 12 weeks Country of Origin - in house manufactured 2 weeks 4 weeks 12 weeks 12 weeks Manufacturing Site in house manufactured 2 weeks 4 weeks 12 weeks 12 weeks Analytical Release Specifications and/or Methods 2 weeks 4 weeks 12 weeks 12 weeks Site - Packaging 2 weeks 4 weeks 12 weeks 12 weeks Site - Finished Product Testing Laboratory 2 weeks 4 weeks 12 weeks 12 weeks Primary Packaging Materials (only catalogue packaging not applicable to custom packaging) Timeline of Notification Prior to Change Diagnostics Elite Products N/A 4 weeks 12 weeks 12 weeks Country of Origin (Procured items) N/A 4 weeks 12 weeks 12 weeks Shipping and Handling N/A 4 weeks 12 weeks 12 weeks Type of Manufacture N/A 4 weeks 12 weeks 12 weeks Biologic country of origin for Starting Material (animal sourced only) N/A N/A 12 weeks 12 weeks Manufacturing Site - Procured N/A N/A 12 weeks 12 weeks Significant Manufacturing Process Changes N/A N/A 12 weeks 12 weeks For more information, visit sigma-aldrich.com/diagnostics 4
5 DIAGNOSTICS ELITE PRODUCTS ON SIGMA-ALDRICH.COM When one of our standard or premium products have a Diagnostics Elite or GMP version available, finding it through our product detail pages is the way to go. Use these few simple tips and Diagnostics Elite products are a click away. Diagnostics Manufacturers and Clinical Labs should use alternative grade product. When you see this statement under Price and Availability, this is a clear indicator that we have the product you are looking for in Elite or GMP grade. Below the pricing and availability you will see an Elite grade ad (left). Clicking on this ad will take you to the corresponding Elite grade product. Diagnostics Elite (Elite or GMP) grade products can be identified by their designation as Suitable for manufacturing of diagnostic kits and reagents. The quality level listed in the properties will also denote Elite or GMP. Sigma-Aldrich Corporation Diagnostics Elite 5
6 COLLABORATION WITH PURPOSE. DIAGNOSTICS ELITE PROCESS AND THE EARLY ACCESS PROGRAM As the Diagnostics Elite program continues to expand, we work diligently to align new optimized products with your evolving needs. One of the ways we do this is through the Early Access Program (EAP). Through this program we provide the opportunity for participating customers to collaborate with us to select and design specifications of new Diagnostic Elite products. The EAP provides participating partners with exclusive access to new Diagnostics Elite products and offers the opportunity for testing and feedback. We will help you minimize the cost and time associated with qualifying our raw materials by gaining a better understanding of how they are used in your products. Our goal is to deliver consistent, high-performing products in alignment with your needs. NEW PRODUCT SELECTION/INITIATION RISK ASSESSMENT & DOCUMENT CREATION QUALIFICATION COLLABORATE THROUGH THE EARLY ACCESS PROGRAM Select products based on customer priorities - Raw materials for new kits - Critical raw materials for existing kits Influence enhanced product specifications Influence format and configuration Joint review of risk factors based on intended product use and required documentation Coordination of manufacturing and testing schedules Feedback of product performance To request more information about our Early Access Program, go to sigma-aldrich.com/diagnosticselite Enabling Science to Improve the Quality of Life Order/Customer Service: sigma-aldrich.com/order Technical Service: sigma-aldrich.com/techservice Development/Custom Manufacturing Inquiries safcglobal@sial.com Safety-related Information: sigma-aldrich.com/safetycenter World Headquarters 3050 Spruce St. St. Louis, MO (314) sigma-aldrich.com 2015 Sigma-Aldrich Co. LLC. All rights reserved. SIGMA, SAFC, SIGMA-ALDRICH, ALDRICH and SUPELCO are trademarks of Sigma-Aldrich Co. LLC, registered in the US and other countries. FLUKA is a trademark of Sigma-Aldrich GmbH, registered in the US and other countries. Sigma-Aldrich, Sigma, Aldrich, Supelco, Fluka and SAFC brand products are sold by affiliated Sigma-Aldrich distributors. Purchaser must determine the suitability of the product(s) for their particular use. Additional terms and conditions may apply. Please see product information on the Sigma-Aldrich website at and/or on the reverse side of the invoice or packing slip. RVQ
Importance of ICH Guidance in Fulfilling Process Validation Requirements
Importance of ICH Guidance in Fulfilling Process Validation Requirements Presented by: Gamal Amer All rights reserved. Do not copy without permission. Principal 1 Premier Compliance Services, Inc. Process
More informationQuality assurance in the supply chain for pharmaceuticals from the WHO perspective
1 Quality assurance in the supply chain for pharmaceuticals from the WHO perspective Dr Sabine Kopp Quality Assurance and Safety: Medicines Medicines Policy and Standards World Health Organization Presentation
More informationAPI hapis High Potency Active Pharmaceutical Ingredients. High Potency Active Pharmaceutical Ingredients. Innovation made. Easy.
API hapis High Potency Active Pharmaceutical Ingredients High Potency Active Pharmaceutical Ingredients Innovation made. Easy. 2 High Potency Active Pharmaceutical Ingredients High potency APIs are our
More informationTaking a broader view
Taking a broader view A brief introduction to DNV GL 1 SAFER, SMARTER, GREENER We are a global classification, certification, technical assurance and advisory company 2 In a challenging world we make businesses
More informationBeware the non-critical excipient
Beware the non-critical excipient Dr Brian A Carlin Director Open Innovation, Chair IPEC QbD Committee brian.carlin@fmc.com ExcipientFest 2012 1 Understand your raw materials http://www.ich.org/uploads/media/q-iwg_web_basic_training.pdf
More informationLeader in Pharmaceutical Films
TSX-V: IGX OTCQX: IGXT Leader in Pharmaceutical Films Your Specialist in Contract Development & Manufacturing WE MAKE APPROVED DRUGS BETTER Our Mission We make approved drugs better, with next generation
More informationQ8 and Q8 annex An industry Perspective
Workshop on Implementation of ICH Q8/Q9/Q10 and Other Quality Guidelines Beijing December 2008 Q8 and Q8 annex An industry Perspective Brian Withers, Abbott Laboratories, United Kingdom I attend this conference
More informationImplementing Quality Systems
Implementing Quality Systems CGMP By The Sea August 29, 2006 Chris Joneckis, Ph.D. Senior Advisor For CMC Issues Center For Biologics Evaluation And Research Add FDA Bar and Presentation Overview Driving
More informationCDER s Office of Pharmaceutical Quality (OPQ): Delivering on the 21 st Century Quality Goals
CDER s Office of Pharmaceutical Quality (OPQ): Delivering on the 21 st Century Quality Goals Lawrence X. Yu, Ph.D. Director (acting) Office of Pharmaceutical Science Food and Drug Administration IFPAC
More informationChallenges of Implementation of ICH Q 8
Challenges of Implementation of ICH Q 8 A Regulatory Perspective Dr. Susanne Keitel BioKorea, Seoul, September 2007 Overview of the Presentation ICH Q 8: Background; EU Experience Design Space Associated
More informationCoatings technology overview
Coatings technology overview Coatings technology and the chemistry of collaboration In a competitive global coatings market, the difference between merely surviving and thriving can often lie in the efficacy
More informationANIMAL FEED ADDITIVES
ANIMAL FEED ADDITIVES Enabling Performance UTRITIVE 5N PLUS Additives GmbH GET TO KNOW 5N PLUS 5N PLUS IS AN INNOVATOR THAT UNLOCKS NEW OPPORTUNITIES 5N Plus is recognized globally for its expertise in
More informationIntegrate, validate, and implement
Integrate, validate, and implement Human Identification Professional Services As the world leader in human identification, Thermo Fisher Scientific continues to develop and deliver technologies, services,
More informationJUST SCRATCHING THE SERVICE
CONTRACT MANUFACTURING, PACKAGING & NEW EQUIPMENT TECHNOLOGY FOR THE BIOPHARM/PHARMACEUTICAL INDUSTRY OFFICIAL MEDIA SPONSOR OF W W W. P H A R M P R O. C O M V O L U M E 3 0, N U M B E R 4 M AY 2 0 1 5
More information2008 Course Programs Schedule
2008 Course Programs Schedule Basic Laboratory Safety Laboratory Safety Biostatistics for the Non-Statistician - Basic Applied cgmps for Pharmaceutical and Allied Industries Good Clinical Practices (GCP)
More informationWRHA Supply Chain New Technology Workshop Supply Chain Forum November 17, 2010
WRHA Supply Chain New Technology Workshop Supply Chain Forum November 17, 2010 Prepared & Presented by: Gwen Connon, Contract Specialist, WRHA Contracting Services Sarah Kelso, Manager, Clinical Engineering,
More informationThe Medical Device Regulation: Transitioning between old and new
Association of British Healthcare Industries The Medical Device Regulation: Transitioning between old and new www.abhi.org.uk www.bdia.org.uk Introduction In May 2017, the new Medical Device Regulation
More informationSTP357: Setting Alert Profile (Supplier)
SAP Training Source To Pay STP357: Setting Alert Profile (Supplier) External User Training Version: 5.5 Last Updated: 21-Jun-2018 3M Business Transformation & Information Technology Progress set in motion
More informationReflections on Innovation, Science, and Society
Reflections on Innovation, Science, and Society Klaus Lindpaintner CSO, Thermo Fisher Scientific 1 The world leader in serving science So: What is Innovation? Is it technology? A sociocultural and socioeconomcal
More informationpure. precise. perfect.
pure. precise. perfect. A Glass Maker Legacy Nipro Corporation, established in 1954, is a global manufacturer of medical devices and glass products. Nipro offers dialysis, transfusion, diagnostics, interventional,
More informationHow to survive the MDR
How to survive the MDR Louis Habets LifetecZONe, 21 September 2017 1 Agenda About the Medical Device Regulation Specific project! Highlights only showing where to find Discussion and Questions LifetecZONe,
More informationOptime Subsea AS. Web: BIC/SWIFT: SPTRN022 IBAN: NO
~Ä TABLE OF CONTENTS TABLE OF CONTENTS... 1 1 Introduction to Optime... 1 2 Products... 2 3 Services... 1 4 Quality, Health, Safety & Environment... 2 5 Partners & Supply chain... 2 1 Introduction to Optime,
More informationTEXTILE TESTING AND CERTIFICATION WORLDWIDE WITH SWISS RELIABILITY
TESTEX AG Swiss Textile Testing Institute Gotthardstrasse 61 P.O. Box 2156 8027 Zurich Switzerland Phone +41 44 206 42 42 Fax +41 44 206 42 30 zuerich@testex.com www.testex.com OETI GmbH Institute for
More informationPROPOSED DOCUMENT. Global Harmonization Task Force. Title: Medical Devices: Post Market Surveillance: Content of Field Safety Notices
SG2(PD)/N57R6 PROPOSED DOCUMENT Global Harmonization Task Force Title: Medical Devices: Post Market Surveillance: Content of Field Safety Notices Authoring Group: Study Group 2 of the Global Harmonization
More informationWelcome to Althea. Welcome to the future of integrated healthcare technology management
Welcome to Althea Welcome to the future of integrated healthcare technology management Modern healthcare systems face a huge challenge: how to offer better care to more people at affordable cost. Technology
More informationIntellectual Property, Vaccine Production and Technology Transfer
Intellectual Property, Vaccine Production and Technology Transfer Vaccine Industry Perspective P. Fournier, On behalf of IFPMA Bio Group 19-20 April 2004, WHO HQ, Geneva 1 OUTLINE General considerations
More informationMAH Responsibilities including the Management of CMOs. QP Forum Workshop. Robert Byrne and Eoin Duff Quality Assurance Alexion Pharmaceuticals
MAH Responsibilities including the Management of CMOs QP Forum 2017 - Workshop Robert Byrne and Eoin Duff Quality Assurance Alexion Pharmaceuticals 25 th April 2017 Alexion Pharmaceuticals in Ireland A
More informationApplied Safety Science and Engineering Techniques (ASSET TM )
Applied Safety Science and Engineering Techniques (ASSET TM ) The Evolution of Hazard Based Safety Engineering into the Framework of a Safety Management Process Applied Safety Science and Engineering Techniques
More informationIMI2 Intellectual Property rules in light of Call 10 topics. Magali Poinot, IMI Legal Manager IMI Stakeholder Forum 28 September 2016
IMI2 Intellectual Property rules in light of Call 10 topics Magali Poinot, IMI Legal Manager IMI Stakeholder Forum 28 September 2016 One policy for multiple interests Support to industry Incentive to participate
More informationQuality by Design, Clinical Relevance & Lifecycle Considerations
Quality by Design, Clinical Relevance & Lifecycle Considerations Robert Iser Acting Director Office of Process & Facilities / OPQ / CDER IFPAC 2016 1 FDA Quality Related Guidance and Initiatives Initiatives
More informationTurning the wheels of your success
INDUSTRIAL SERVICES Turning the wheels of your success A comprehensive package of integrated services combining traditional certification and inspection with innovative business solutions based on the
More informationRequirements in Other Countries PQRI+USP EI Workshop; Rockville, MD, Dr. Helmut Rockstroh
Requirements in Other Countries PQRI+USP EI Workshop; Rockville, MD, 2015 Dr. Helmut Rockstroh Overview Introduction - Scope Pharmacopoeial + HA Positions Examples / Case Studies Discussion 2 Introduction:
More informationTechnically Unavoidable Particles Profile (TUPPs) Guide
Technically Unavoidable Particles Profile (TUPPs) Guide Priscilla Zawislak Global Regulatory Affairs Manager Ashland Inc. Chair Elect, IPEC-Americas pszawislak@ashland.com www.ipecamericas.org 1 Agenda
More informationMedical Technology Association of NZ. Proposed European Union/New Zealand Free Trade Agreement. Submission to Ministry of Foreign Affairs & Trade
Medical Technology Association of NZ Proposed European Union/New Zealand Free Trade Agreement Submission to Ministry of Foreign Affairs & Trade February 2016 1 Introduction The Medical Technology Association
More informationpeace of mind For from development to commercial supply
For peace of mind from development to commercial supply aesica-pharma.com weshouldtalk@aesica-pharma.com @aesica CorporateBroEng_v2 0814 @ Aesica 2014 Your full service CDMO Our vision: To be the number
More informationTechnology Transfer Plays an Increasingly Important Role in Pharmaceutical Quality Systems
Technology Transfer Plays an Increasingly Important Role in Pharmaceutical Quality Systems A robust and secure manufactured product is the desired end result for pharmaceutical companies. Scale-up and
More informationPharmaceutical Manufacturing and Engineering Catalog Excerpt
Pharmaceutical Manufacturing and Engineering Catalog Excerpt PME 530 Introduction to Pharmaceutical Manufacturing Pharmaceutical manufacturing is vital to the success of the technical operations of a pharmaceutical
More informationGlobal Regulatory Update FDA, USP, EP and ICH Standards for Test Method Validation. Jane Weitzel
Global Regulatory Update FDA, USP, EP and ICH Standards for Test Method Validation Jane Weitzel mljweitzel@msn.com Jane Weitzel Biosketch Jane Weitzel has been working in analytical chemistry for over
More informationFINAL DOCUMENT. Title: Medical Devices Post Market Surveillance: Content of Field Safety Notices. Endorsed by: The Global Harmonization Task Force
GHTF/SG2/N57R8:2006 FINAL DOCUMENT Title: Medical Devices Post Market Surveillance: Content of Field Safety Notices Authoring Group: Study Group 2 Endorsed by: The Global Harmonization Task Force Date:
More informationEXTRAORDINARY EVENTS CALL FOR EXTRAORDINARY DESIGNERS
EXTRAORDINARY EVENTS CALL FOR EXTRAORDINARY DESIGNERS SPACES REIMAGINED At M&IW, we believe live meetings and events transform organizations. And, we know that the better the experience the more magic
More informationSmartZone Rack Energy Kits. Power and Environmental Monitoring for Small Data Centers
SmartZone Rack Energy Kits Power and Environmental Monitoring for Small Data Centers 3 Simple Steps to Success Step 1: Order + Step 2: Install + Step 3: Monitor = Simple To Order All necessary hardware
More informationTRIPS and Access to Medicines. WR Briefing
TRIPS and Access to Medicines WR Briefing Outline What is TRIPS How does it affect access to medicines What are the TRIPS flexibilities? What are extra-trips provisions? How do the extra-trips provisions
More informationCurrent Status and Challenges of Bilateral/Multilateral Meetings
Current Status and Challenges of Bilateral/Multilateral Meetings Junko Sato, PhD International Liaison Officer PMDA 26th Annual EuroMeeting 25-27 March 2014 ACV, Vienna Austria Disclaimer The views and
More informationWHITE PAPER FACILITY FOCUS: GMP Facility Modernization. By: David M. Marks, P.E.
WHITE PAPER FACILITY FOCUS: GMP Facility Modernization By: David M. Marks, P.E. July 2017 Introduction In recent years, intensified industry competition and cost pressures have renewed interest in modernizing
More informationRosatom Approach to IPR Management in Collaborative Projects on Innovations
State Atomic Energy Corporation Rosatom Rosatom Approach to IPR Management in Collaborative Projects on Innovations Natalia Belenkaya Project Leader, Innovation Management ROSATOM Vienna, IAEA November
More informationEU GMP Evolution or Revolution Scope and drivers for EU GMP changes. August Gordon Farquharson
EU GMP Evolution or Revolution Scope and drivers for EU GMP changes August 2015 Gordon Farquharson EU & PIC/S Harmonisation at IWG level now Slide 2 PharmOut 2015 EU & PIC/S Harmonisation (1) What does
More informationAn Exclusive Brokered Brand for China, S. Korea, Mongolia, and the Philippines SLC Global LLC
An Exclusive Brokered Brand for China, S. Korea, Mongolia, and the Philippines SLC Global LLC 1 INDEX Slide 3: History of Sheffield Pharmaceuticals Slide 4: Why Sheffield Pharmaceuticals Slide 5 15: Sheffield
More informationEnvironmental Protection Agency
Good Laboratory Management: Means compliance with the correct regulations for each individual study.. Environmental Protection Agency Established 1970 To enforce environmental protection standards Clean
More informationQbD Application in Japan: PMDA Perspective
CMC Strategy Forum Japan 2013 Hotel Okura, Tokyo, Japan, December 9 10, 2013 QbD Application in Japan: PMDA Perspective Yasuhiro Kishioka, PhD. Reviewer Office of Cellular and Tissue based Products Pharmaceuticals
More informationUpdate on Progress Implementing the LSIF Anti- Counterfeit Medicines Action Plan
2013/SOM1/LSIF/009 Agenda item: 17 Update on Progress Implementing the LSIF Anti- Counterfeit Medicines Action Plan Purpose: Information Submitted by: United States Life Sciences and Innovative Forum Planning
More informationISO/FDIS Requirements for Traceability of Values Assigned to IVD Calibrators and Controls: A Viewpoint from US Industry
ISO/FDIS 17511 - Requirements for Traceability of Values Assigned to IVD Calibrators and Controls: A Viewpoint from US Industry JCTLM, June 10, 2002 Neil Greenberg, PhD Representing ADVAMED Manager, Regulatory
More informationOur view on innovation.
Our view on innovation. Your added value new advanced Technology established advanced established Market new established Product advanced new 2 When seeing becomes receiving. Gaining access to and thus
More informationADDING VALUE TO YOUR BUSINESS
Developed by experts made for tooling Uddeholm AM Corrax ADDING VALUE TO YOUR BUSINESS #1 IN HIGH PERFORMANCE TOOL STEEL With pioneering research and development, innovative thinking and deep commitment,
More informationSTRATEGIES FOR SUCCESSFUL SCALE-UP USING QUALITY BY DESIGN
STRATEGIES FOR SUCCESSFUL SCALE-UP USING QUALITY BY DESIGN CHRISTOPHER J POTTER ISPE ADVISOR AND CMC CONSULTANT 1 AGENDA Background ICH Guidelines Terms and Definitions Supporting Information ISPE publications
More informationDigital Medical Device Innovation: A Prescription for Business and IT Success
10 September 2018 Digital Medical Device Innovation: A Prescription for Business and IT Success A Digital Transformation is reshaping healthcare. New technology, mobility, and advancements in computing
More informationPROTECTING YOUR GOODS, AND YOUR GOOD NAME
PROTECTING YOUR GOODS, AND YOUR GOOD NAME UL IS A GLOBAL, INDEPENDENT SAFETY SCIENCE COMPANY with more than a century of expertise innovating safety solutions and dedicated to promoting safe living and
More informationPreparing for the new Regulations for healthcare providers
Preparing for the new Regulations for healthcare providers Cathal Brennan, Medical Device Assessor HPRA Information Day on Medical Devices 23 rd October 2014 Brussels, 26.9.2012 COM(2012) 542 final 2012/0266
More informationWHITE PAPER FACILITY FOCUS: Next Generation Aseptic Manufacturing: An Eye-Opening Peek into the Future. By: Hite Baker
WHITE PAPER FACILITY FOCUS: Next Generation Aseptic Manufacturing: An Eye-Opening Peek into the Future By: Hite Baker August 2017 Introduction This Facility Focus Survey Report explores how to design sterile
More informationQwikCheck Beads Precision and Linearity Kit Instructions QwikCheck GOLD Analyzer
Medical Electronic Systems www.mes-global.com service@mes-llc.com QwikCheck Beads Precision and Linearity Kit Instructions QwikCheck GOLD Analyzer OVERVIEW The QwikCheck Beads Precision and Linearity Kit
More informationVenture Capital Search Highlights
Venture Capital Venture funding continued at the strongest pace witnessed over the past decade in 2016, and recruiting the future leaders of the industry s emerging growth companies has never been more
More informationDecember Eucomed HTA Position Paper UK support from ABHI
December 2008 Eucomed HTA Position Paper UK support from ABHI The Eucomed position paper on Health Technology Assessment presents the views of the Medical Devices Industry of the challenges of performing
More informationDSM Sinochem Pharmaceuticals
DSM Sinochem Pharmaceuticals 140 years of innovation February 2015 Cover photo: daisy in gras, istock Safe Harbor Statement Although diligent care has been used to ensure that the information provided
More informationVENUE. 2 DAY WORKSHOP On FDA Penalties for Regulatory Non-Compliance in the Pharmaceuticals Industry in Review , JAN San Diego CA
WORLD COMPLIANCE SEMINARS SPEAKER:- BRIAN G. NADEL President of Brian G. Nadel, GMP Consulting, LLC. 2 DAY WORKSHOP On FDA Penalties for Regulatory Non-Compliance in the Pharmaceuticals Industry - 2017
More informationNIHR / Wellcome Trust King s Clinical Research Facility. Guidance for Investigators
NIHR / Wellcome Trust King s Clinical Research Facility Guidance for Investigators Introduction The NIHR Clinical Research Facilities provide dedicated facilities to support the delivery of externally-funded
More informationIntroduction to IP: Some Basics of Patents, Trademarks, & Trade Secrets
Introduction to IP: Some Basics of Patents, Trademarks, & Trade Secrets Tom Cowan July 28, 2016 knobbe.com What is Intellectual Property (IP)? Exclusive Rights to Certain Intellectual Products (Ideas)
More informationBeyond beads. Develop high performance assays, fast
Beyond beads Develop high performance assays, fast Agilent goes beyond the bead to help you develop high performance assays, fast As manufacturers of in vitro diagnostic (IVD) assays, you demand high-performance
More informationTechnology and Innovation in the NHS Scottish Health Innovations Ltd
Technology and Innovation in the NHS Scottish Health Innovations Ltd Introduction Scottish Health Innovations Ltd (SHIL) has, since 2002, worked in partnership with NHS Scotland to identify, protect, develop
More informationICH Q12 (Pharmaceutical Product Lifecycle Management): PMDA Perspective
14 th DIA Japan Annual Meeting 2017 November 12-14, 2017 Tokyo Big Sight Ariake ICH Q12 (Pharmaceutical Product Lifecycle Management): PMDA Perspective Yasuhiro Kishioka, Ph.D. Principal Reviewer Office
More informationART CONSULTANT CAREER GUIDE
ART CONSULTANT CAREER GUIDE Corporate Art Force, LLC DBA Art Force 1400 Van Buren Street N.E. Suite 175 Minneapolis, MN 55413 Phone: 763-567-2200 www.artforce.org Art Force - Art Consultant Career Guide
More informationIndustry at a Crossroads: The Rise of Digital in the Outcome-Driven R&D Organization
Accenture Life Sciences Rethink Reshape Restructure for better patient outcomes Industry at a Crossroads: The Rise of Digital in the Outcome-Driven R&D Organization Accenture Research Note: Key findings
More informationDreamCatcher Agile Studio: Product Brochure
DreamCatcher Agile Studio: Product Brochure Why build a requirements-centric Agile Suite? As we look at the value chain of the SDLC process, as shown in the figure below, the most value is created in the
More informationThis is a preview - click here to buy the full publication
TECHNICAL REPORT IEC/TR 62794 Edition 1.0 2012-11 colour inside Industrial-process measurement, control and automation Reference model for representation of production facilities (digital factory) INTERNATIONAL
More informationGlobal Perspectives on Clinical Engineering Trends Yadin David, Ed.D., P.E., C.C.E., FAACE, FAIMBE
Second WHO Global Forum on Medical Devices Priority Medical Devices for Universal Health Coverage 22-24 November 2013, Geneva, Switzerland Global Perspectives on Clinical Engineering Trends Yadin David,
More informationBiomedical Equipment Technician
Biomedical Equipment Technician Occupational Skill Stards Texas Skill Stards Board Recognized Critical Work Function 1. Install Biomedical Equipment 1.1 Receive, inspect inventory upon delivery 1.2 Deliver
More informationTest, Validation and Regulatory Requirements for Medical Electronics
Test, Validation and Regulatory Requirements for Medical Electronics 1 Life Cycle Approach 2 Why Risk Risks and associated measures are called in the following regulations / standards: 43 sections in the
More informationPHARMACEUTICAL QUALITY MANAGEMENT SYSTEM: A REVIEW
PHARMACEUTICAL QUALITY MANAGEMENT SYSTEM: A REVIEW Available online at www.ijdra.com REVIEW ARTICLE Sharma S*, Bodla R.B., Shweta S, Pathak D.P. Delhi Institute of Pharmaceutical Sciences and Research,
More informationHTA Position Paper. The International Network of Agencies for Health Technology Assessment (INAHTA) defines HTA as:
HTA Position Paper The Global Medical Technology Alliance (GMTA) represents medical technology associations whose members supply over 85 percent of the medical devices and diagnostics purchased annually
More informationInter-Association Task Force
Inter-Association Task Force Presentation to EMA Workshop Prevention of Drug Shortages Based on Quality and Manufacturing Issues 9 th October 2015 1 Topics for Today Background and history of task force
More informationBuilt on Trust Table of Contents Company Overview Our Vision and Mission Statement Services Smelting Minting Precious Stones & Diamond Separation Assaying Refining Trading Range of Casted Products Customized
More informationQuality Risk Management
Quality Risk Management Iron Chef Edition Keith D. Gibbs kage and sui generis Ninja Project Management My story shapes my perspective Bachelor of Science work in Earth Science with focus on Hydrogeology.
More informationSwissmedic, Swiss Agency for Therapeutic Products
PMDA International Forum, 8 February 2014 Swissmedic, Swiss Agency for Therapeutic Products Jürg H. Schnetzer, Executive Director Grüezi. Bonjour. Buongiorno. Allegra. 2 Overview Swissmedic Introduction
More informationFuture of Pharmaceutical Quality and the Path to Get There
Future of Pharmaceutical Quality and the Path to Get There Lawrence Yu, Ph.D. Deputy Director, Office of Pharmaceutical Quality FDA Center for Drug Evaluation and Research INTERPHEX 2018, April 18, 2018,
More informationLundbeck s view on the EU IP systems
Lundbeck s view on the EU IP systems Forårsmøde IPR in the EU May 26 2011 H. Lundbeck A/S 1 Agenda The Innovative Pharmaceutical Industry and why IP is so important for Lundbeck Lundbeck s wish list for
More informationChallenges, benefits, case study
hallenges, benefits, case study Pharmaceutical development phases overview The new paradigm for development: Quality by Design (QbD) hallenges Benefits ase study losure and Q&A»»»»»» D. eriani Meet MINITAB,
More informationMedicines Manufacturing in the UK 2017
Medicines Manufacturing in the UK 2017 Moderator: Magda Papadaki, PhD Head of Manufacturing Innovation The Association of the British Pharmaceutical Industry Medicines Manufacturing Industry Partnership
More informationOverview on Medicines Regulation: regulatory cooperation and harmonization in focus
Overview on Medicines Regulation: regulatory cooperation and harmonization in focus Dr Samvel Azatyan Manager, Medicines Regulatory Support Programme Quality Assurance and Safety: Medicines Essential Medicines
More informationIP and Technology Management for Universities
IP and Technology Management for Universities Yumiko Hamano Senior Program Officer WIPO University Initiative Innovation and Technology Transfer Section, Patent Division, WIPO Outline! University and IP!
More informationFresenius Medical Care North America (FMCNA)
4 th Annual Lab Quality Confab and Process Improvement Institute November 2 3, 2010 Spectra Labs Turns to ISO 15189 s QMS to Advance Performance and Gain International Recognition Presented by: Chinu M.
More informationWHO WE ARE MISSION STATEMENT
WHO WE ARE Parker Life Sciences offers reliable fluidic and motion control products, MetaModules, and systems to customers in life sciences and in analytical instrumentation markets. As part of Parker
More informationICH Q8, 9 & 10 and the Impact on the QP
1 ICH Q8, 9 & 10 and the Impact on the QP Peter H. Gough David Begg Associates phg@david-begg-associates.com 2 A New Approach to Regulation Approach to the regulation of pharmaceuticals is undergoing a
More informationTranslational Medicine Symposium 2013: The Roller Coaster Ride to the Clinic
Translational Medicine Symposium 2013: The Roller Coaster Ride to the Clinic Meet the Entrepreneurial Faculty Scholars 1 Translational Medicine Symposium 2013 Bench to Business to Bedside: The Roller Coaster
More informationWG food contact materials
WG food contact materials Monday 30 January European Commission DG SANTE, Unit E2 Food Processing Technologies and Novel Foods Food Contact Materials This presentation does not present any official views
More informationHow To Draft Patents For Future Portfolio Growth
For the latest breaking news and analysis on intellectual property legal issues, visit Law today. www.law.com/ip Portfolio Media. Inc. 860 Broadway, 6th Floor New York, NY 10003 www.law.com Phone: +1 646
More informationQuality Regulation under Revised Pharmaceutical Affair Law
Quality Regulation under Revised Pharmaceutical Affair Law Yukio Hiyama, Ph.D. Division of Drugs, National Institute of Health Sciences, the Ministry of Health, Labour and Welfare, Japan E mail hiyama@nihs.go.jp
More informationProcedure for Obtaining Verification of a Stormwater Manufactured Treatment Device from New Jersey Corporation for Advanced Technology
Procedure for Obtaining Verification of a Stormwater Manufactured Treatment Device from New Jersey Corporation for Advanced Technology For use in accordance with the Stormwater Management Rules, N.J.A.C.
More informationPyroGenesis Announces Receipt of AS9100D Certification for Aviation, Space, and Defense Industries; Provides Update on AM Business Line
PyroGenesis Announces Receipt of AS9100D Certification for Aviation, Space, and Defense Industries; Provides Update on AM Business Line MONTREAL, QUEBEC (GlobeNewswire November 13 th, 2018) - PyroGenesis
More informationCESSNA QUALITY REQUIREMENTS. For SUPPLIERS (CQRS)
CESSNA QUALITY REQUIREMENTS For SUPPLIERS (CQRS) Textron Aviation Page i Export Compliance Revision Export Control Classification N/C-L - M EAR99 N EAR99 O EAR99 P EAR99 Restrictions: None. Textron Aviation
More informationQUESTIONS & ANSWERS 1
QUESTIONS & ANSWERS 1 DETOX TO ZERO by OEKO-TEX As many of you know, Greenpeace launched their Detox campaign in 2011 to shed light on toxic water pollution issues that a portion of the global apparel
More informationCorporate Mind 2013 Corporate Responsibility Report
Corporate Mind 2013 Corporate Responsibility Report Artwork: artist s rendering of a protease (yellow) cleaving a protein. Artist s rendering of a protease (yellow) cleaving a protein. Corporate Mind Promega
More informationBrazilian industry s activities for international convergence. Walker Lahmann Director of External Trade at ABIFINA Executive Director at Eurofarma
Brazilian industry s activities for international convergence Walker Lahmann Director of External Trade at ABIFINA Executive Director at Eurofarma Mission Congregate companies, institutes and association
More information